FindTrial
Sign In

G-CSF priming and cladribine plus cytarabine included conditioning regimen in hematopoetic transplantation of high risk or refractory acute leukemia

G-CSF priming and cladribine plus cytarabine included conditioning regimen in hematopoetic transplantation of high risk or refractory acute leukemia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021059
Enrollment
Unknown
Registered
2019-01-27
Start date
2019-02-01
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute leukemia

Interventions

Experimental group:G-csf priming and cladribine plus cytarabine included conditioning regimen
Control group:traditional condition regimen

Sponsors

Xin Qiao hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: high risk acute leukemia; refractory acute leukemia

Exclusion criteria

Exclusion criteria: No

Design outcomes

Primary

MeasureTime frame
disease free survival;—

Countries

China

Contacts

Public ContactYao Han

Xinqiao Hospital

546686852@qq.com+86 13996014516

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026